All Articles

With relegation looming, a new analysis reveals Tottenham faces a £181.5M first-year loss, threatening its stadium-sized debt and top-flight future.

Taiwan's SynbioTech is launching a science-backed probiotic portfolio at Vitafoods Europe, targeting a holistic approach to women's active aging.

A new AI scans children's phone calls for risk, promising safety without human snooping. But does this protection come at the cost of privacy and trust?

With CHF 2.5 million in new seed funding, Swiss-based Oberland Biotech is set to tackle the competitive US and Asian nutritional food markets.

A new gene therapy has helped completely blind patients with Retinitis Pigmentosa regain light perception, offering hope to millions with inherited blindness.

Aalberts N.V. returns to organic growth in Q1 2026, driven by its 'thrive 2030' strategy, successful acquisitions, and operational improvements.

A landmark Carnegie Hall concert saw young U.S. and Chinese musicians use AI to compose new works, blending tradition with tech to foster global unity.

This Gen Z startup's viral AI videos are moving education beyond simple answers, attracting millions of users and major enterprise interest.

A Moscow forum on global growth is advancing Russia's geopolitical goal of a multipolar world, using tech sovereignty and 'joint development' to court allies.

As fuel prices soar in Australia and New Zealand, businesses are overlooking a bigger threat: the spiraling, hidden labour costs from operational chaos.

ESS Tech partners with Alsym Energy, adding 8.5 GWh of safe, non-flammable sodium-ion batteries to challenge lithium-ion's market dominance.

McEwen Inc. completes its acquisition of Golden Lake, integrating the Jewel Ridge project to create a long-life gold mining complex in Nevada's core.

At interpack 2026, TekniPlex unveils talc-free gaskets and polystyrene alternatives, engineering a new standard for compliance and sustainability.

Bill Ackman takes to X Spaces to answer for his new funds' rocky debut. What's the strategy behind the dual IPO and can he calm investor nerves?

Medtech firm TELA Bio overhauls its board with M&A and turnaround experts, signaling a major strategic shift to accelerate growth and escape losses.

With its fourth major Brazilian acquisition, Evertec buys Dimensa to capture a larger share of Latin America's most dynamic financial technology market.

Collective Acquisition Corp. II, led by finance vets and military leaders, closes a $220M IPO to hunt for deals in defense tech, AI, and strategic resources.

A massive lawsuit plunged the brewer into a deep quarterly loss, overshadowing operational gains and highlighting struggles in a shifting beverage market.

A major financing deal preserves critical affordable housing in a high-cost DC area, offering a lifeline to residents and a blueprint for urban renewal.

The chemical giant's Q1 earnings fell year-over-year, but strong sequential growth and a "net upside" from global conflict fuel an optimistic 2026 outlook.